Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CYTK
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | B. Lynne Parshall Director | CYTK Cytokinetics, Incorporated | Sale | 2,555 | $55.26 | $141.2K Sale | Form 4 ↗ |
| Nov 9, 2026 | B. Lynne Parshall Director | CYTK Cytokinetics, Incorporated | Sale | 2,445 | $54.17 | $132.4K Sale | Form 4 ↗ |
| Nov 3, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $62.93 | $220.3K Sale | Form 4 ↗ |
| Nov 2, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $62.81 | $471.1K Sale | Form 4 ↗ |
| Oct 20, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $64.01 | $224.0K Sale | Form 4 ↗ |
| Sep 28, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $65.46 | $490.9K Sale | Form 4 ↗ |
| Sep 22, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $68.29 | $239.0K Sale | Form 4 ↗ |
| Sep 15, 2026 | Robert E. Landry Director | CYTK Cytokinetics, Incorporated | Sale | 1,000 | $72.13 | $72.1K Sale | Form 4 ↗ |
| Sep 15, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 97,926 | $69.33 | $6.8M Sale | Form 4 ↗ |
| Sep 14, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $73.44 | $550.8K Sale | Form 4 ↗ |
| Sep 11, 2026 | Robert E. Landry Director | CYTK Cytokinetics, Incorporated | Sale | 1,000 | $74.66 | $74.7K Sale | Form 4 ↗ |
| Sep 8, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $75.46 | $264.1K Sale | Form 4 ↗ |
| Sep 1, 2026 | B. Lynne Parshall Director | CYTK Cytokinetics, Incorporated | Sale | 5,000 | $71.48 | $357.4K Sale | Form 4 ↗ |
| Aug 31, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 10,000 | $70.24 | $702.4K Sale | Form 4 ↗ |
| Aug 31, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $70.24 | $526.8K Sale | Form 4 ↗ |
| Aug 18, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $75.82 | $265.4K Sale | Form 4 ↗ |
| Aug 10, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $76.76 | $575.7K Sale | Form 4 ↗ |
| Jul 30, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 14,000 | $79.88 | $1.1M Sale | Form 4 ↗ |
| Jul 27, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $80.87 | $606.5K Sale | Form 4 ↗ |
| Jul 21, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $80.59 | $282.1K Sale | Form 4 ↗ |
| Jul 13, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,490 | $82.02 | $614.3K Sale | Form 4 ↗ |
| Jul 13, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 10 | $82.02 | $820 Sale | Form 4 ↗ |
| Jul 7, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $86.62 | $303.2K Sale | Form 4 ↗ |
| Jul 1, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $84.92 | $636.9K Sale | Form 4 ↗ |
| Jul 1, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 15,000 | $85.80 | $1.3M Sale | Form 4 ↗ |
| Jul 1, 2026 | Sung Lee EVP, Chief Financial Officer | CYTK Cytokinetics, Incorporated | Sale | 1,112 | $87.79 | $97.6K Sale | Form 4 ↗ |
| Jun 29, 2026 | Sung Lee EVP, Chief Financial Officer | CYTK Cytokinetics, Incorporated | Sale | 3,134 | $85.00 | $266.4K Sale | Form 4 ↗ |
| Jun 24, 2026 | Sung Lee EVP, Chief Financial Officer | CYTK Cytokinetics, Incorporated | Sale | 38,730 | $82.30 | $3.2M Sale | Form 4 ↗ |
| Jun 23, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $79.51 | $278.3K Sale | Form 4 ↗ |
| Jun 15, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $70.46 | $528.5K Sale | Form 4 ↗ |
| Jun 9, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $67.98 | $237.9K Sale | Form 4 ↗ |
| Jun 1, 2026 | Edward M. Kaye MD Director | CYTK Cytokinetics, Incorporated | Sale | 2,933 | $76.09 | $223.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 15,000 | $74.08 | $1.1M Sale | Form 4 ↗ |
| Jun 1, 2026 | B. Lynne Parshall Director | CYTK Cytokinetics, Incorporated | Sale | 5,000 | $74.08 | $370.4K Sale | Form 4 ↗ |
| May 27, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $77.21 | $579.1K Sale | Form 4 ↗ |
| May 19, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $75.69 | $264.9K Sale | Form 4 ↗ |
| May 14, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $77.92 | $584.4K Sale | Form 4 ↗ |
| May 5, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $77.37 | $270.8K Sale | Form 4 ↗ |
| May 5, 2026 | Wendell Wierenga Director | CYTK Cytokinetics, Incorporated | Sale | 4,032 | $75.00 | $302.4K Sale | Form 4 ↗ |
| May 5, 2026 | Sung Lee EVP, Chief Financial Officer | CYTK Cytokinetics, Incorporated | Sale | 23,906 | $76.87 | $1.8M Sale | Form 4 ↗ |
| May 5, 2026 | John T. Henderson Director | CYTK Cytokinetics, Incorporated | Sale | 20,000 | $75.97 | $1.5M Sale | Form 4 ↗ |
| May 5, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 11,333 | $77.25 | $875.5K Sale | Form 4 ↗ |
| May 1, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 15,857 | $65.00 | $1.0M Sale | Form 4 ↗ |
| Apr 30, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 15,000 | $63.26 | $948.9K Sale | Form 4 ↗ |
| Apr 29, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $59.62 | $447.1K Sale | Form 4 ↗ |
| Apr 21, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $65.69 | $229.9K Sale | Form 4 ↗ |
| Apr 15, 2026 | Andrew Callos EVP, Chief Commercial Officer | CYTK Cytokinetics, Incorporated | Sale | 7,449 | $66.02 | $491.8K Sale | Form 4 ↗ |
| Apr 15, 2026 | Robert I. Blum President & CEO, Director | CYTK Cytokinetics, Incorporated | Sale | 7,500 | $65.38 | $490.4K Sale | Form 4 ↗ |
| Apr 7, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 1,000 | $64.75 | $64.8K Sale | Form 4 ↗ |
| Apr 7, 2026 | Fady Ibraham Malik EVP Research & Development | CYTK Cytokinetics, Incorporated | Sale | 3,500 | $65.21 | $228.2K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:24 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances